Abstract CT051: SKYSCRAPER-01: A phase III, randomized trial of tiragolumab (tira) + atezolizumab (atezo) versus placebo (pbo) + atezo in patients (pts) with previously-untreated PD-L1-high, locally advanced unresectable/metastatic NSCLC
Year: 2025
Type: conference-abstract
Source: Cancer Research
Authors: Solange Peters, Roy Herbst, Hidehito Horinouchi, Luis Paz-Ares, Melissa Johnson, Benjamin Solomon, Mahmut Gumus, Mustafa Erman, Igor Bondarenko, Dong-Wan Kim, Enriqueta Felip, Alessandro Morabito, Maciej Bryl, Raymond Meng, Chipman Stroud, Palak Kundu, Xiaohui Wen, Namrata Patil, Meilin Huang, Byoung Chul Cho
Institutions: Centre Hospitalier Universitaire Vaudois, Yale Cancer Center, Yale University, National Cancer Center Hospital, Hospital Universitario 12 De Octubre, Sarah Cannon, Peter MacCallum Cancer Centre, Istanbul Medeniyet University, Hacettepe University, Dnipro State Medical University, Seoul National University, Seoul National University Hospital, Vall d'Hebron Hospital Universitari, Vall d'Hebron Institute of Oncology, Istituto Nazionale Tumori IRCCS "Fondazione G. Pascale", Poznan University of Medical Sciences, Yonsei University, Yonsei University Health System, Yonsei Cancer Hospital
Language: English
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W4409822175